Asset Manager

Updated:

RCM Technologies

RCM Technologies: Bradley Vizi's publicly traded engineering and healthcare services consolidator, operating via three segments and an acquisition-driven...

RCM Technologies

RCM Technologies operates as a publicly traded holding company focused on specialized professional services. The business runs through three operating segments: Engineering, Specialty Health Care, and Life Sciences and Information Technology. Engineering provides industrial, energy, and process control solutions. Specialty Health Care places nurses and care professionals in schools and long-term care facilities. The IT and Life Sciences unit delivers enterprise software implementation and staffing for pharmaceutical and biotech clients. Under Executive Chairman Bradley Vizi, the firm has shifted strategy from broad IT staffing toward rolling up technical services firms with recurring relationships. Capital allocation prioritizes acquisition of niche consultancies that generate predictable cash flows. The company does not raise external funds or operate as a family office. It is a Nasdaq-listed enterprise with shares trading under the ticker RCMT, giving the public a direct view into its financial performance. With no disclosed private fund structure, RCM Technologies deploys capital directly from its balance sheet. The company maintains a lean corporate office while operating units run with significant autonomy. Recent public filings show a focus on converting trailing revenue into smaller bolt-on acquisitions in the engineering and healthcare staffing verticals. RCM Technologies' structural differentiator is its public-company transparency paired with a roll-up mentality typically seen in private equity. Instead of holding periods constrained by fund lifecycles, Vizi's entity can hold acquisitions indefinitely, using its public currency when accretive. This permanent-capital structure allows the firm to compete with private acquirers for family-founded engineering and healthcare consultancies seeking long-term stewardship rather than a short flip.

Website
rcmt.com

General information

Firm type

Asset Manager

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Corporate office

Principals

Bradley Vizi

Executive Chairman and President

Sector focus

Industrial TechHealthcare ServicesEnterprise Software

Frequently asked questions

Who runs investment decisions at RCM Technologies?

Bradley Vizi, as Executive Chairman and President, leads capital allocation and acquisition strategy. The company does not maintain a separate investment committee publishing independent decisions. Material acquisitions are reviewed by the board of directors consistent with Nasdaq-listed company governance.

Is RCM Technologies a family office, private equity fund, or a public company?

It is a publicly traded corporation listed on Nasdaq under the ticker RCMT. While its capital allocation model resembles a permanent-capital private equity vehicle, RCM Technologies reports quarterly earnings, files with the SEC, and allows any investor to purchase shares through the open market.

How does RCM Technologies source acquisition targets?

The firm pursues proprietary outreach to founder-owned engineering and healthcare consultancies. It evaluates businesses through its internal leadership at the segment level rather than relying on competitive auction processes. Public filings emphasize the company's ability to close quickly and integrate without the fund-lifecycle pressures that define private equity.

What investment stages does RCM Technologies target?

The company acquires mature, cash-flowing professional services firms rather than investing in early-stage or venture-backed companies. Target businesses typically have established client rosters, recurring revenue, and management teams willing to stay post-acquisition.

Which sectors does RCM Technologies explicitly avoid?

Public disclosures show no involvement in consumer-facing technology, direct-to-consumer startups, or speculative biotech. The firm concentrates solely on engineering services, healthcare staffing, and enterprise technology implementation for deeply regulated industries.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo